Research Article
Plasm Metabolomics Study in Pulmonary Metastatic Carcinoma
Table 1
Comparison of general characteristics.
| | | PMC | BPN | PLC | HPG | Value |
| | No | 16 | 32 | 80 | 48 | |
| | Age, y ± SD | 55.2 ± 8.9 | 56.3 ± 8.9 | 55.0 ± 9.2 | 53.2 ± 9.2 | 0.317 |
| | Sex, n (%) | | | | | 0.587 | | Male | 12 (75.0) | 24 (75.0) | 57 (71.3) | 35 (72.9) | | | Female | 4 (25.0) | 8 (25.0) | 23 (28.7) | 13 (27.1) | |
| | Smoking history, n (%) | | | | | 0.069 | | Yes | 10 (62.5%) | 14 (43.8) | 33 (41.3) | 19 (39.6) | | | No | 6 (37.5%) | 18 (56.2) | 47 (58.7) | 29 (60.4) | |
| | Comorbidity, n (%) | | | | | 0.345 | | Yes | 7 (43.8) | 13 (40.6) | 27 (33.8) | 15 (31.3) | | | No | 9 (56.2) | 19 (59.4) | 53 (66.2) | 33 (68.2) | |
| | Tumor site, n (%) | | LUL | 4 (25.0) | 4 (12.5) | 21 (26.2) | | | | LLL | 3 (18.8) | 6 (18.8) | 12 (15.0) | | | | RUL | 7 (43.8) | 5 (15.6) | 23 (28.8) | | | | RML | 0 | 1 (3.1) | 4 (5.0) | | | | RLL | 1 (6.2) | 12 (37.5) | 12 (15.0) | | | | Two or more | 1 (6.2) | 4 (12.5) | 8 (10.0) | | |
| | Pathology types, n (%) | | Ad | 13 (81.1) | | 65 (81.2) | | | | SC | 0 | | 10 (12.4) | | | | SCLC | 0 | | 2 (2.5) | | | | Carcinoid | 0 | | 1 (1.3) | | | | Carcinosarcoma | 0 | | 1 (1.3) | | | | LCLC | 0 | | 1 (1.3) | | | | ACC | 1 (6.3) | | 0 | | | | Others | 2 (12.6) | | 0 | | |
|
|
